SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
440.00    15.00 (3.53%)
Bid:
430.00
Ask:
450.00
Spread: 20.00 (4.651%)
Market Cap: £77.77m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

Contract win

23 May 2006 07:01

TG21 Plc23 May 2006 TG21 plc ("the Company") announces agreement with Biodata Limited For release: 23 May 2006 TG21 plc today announces that its subsidiary 21st Century Crime PreventionServices Limited ("21st Century") has today signed an agreement with BiodataLimited ("Biodata") for the exclusive rights to Biodata's people counting systemwhen interfaced with public transport vehicle systems. 21st Century is a leading provider of on-board CCTV to the UK bus market and isalso developing several new products for the public transport market. The firsttwo of these, Revenue-Manager(TM) and Eco-Manager(TM), are aimed at enhancingrevenue and reducing running costs for bus operators. The Biodata system knownas "Video Turnstile" uses their technology in conjunction with overhead CCTV tocount passengers entering and leaving a vehicle. The Video Turnstile will beinterfaced with fare revenue data from the ticketing machines and automaticallytransmit an audit report back to the control centre as each bus returns to itsdepot. Biodata are also developing an interface to the Eco-Manager product whichis aimed at reducing fuel and maintenance costs for bus operators by monitoringand reporting on driver behaviour. A major public transport company has alreadyagreed to run trials with 21st Century for both Revenue-Manager and Eco-Manageron 54 of its buses. Peter Ward, Chairman of TG21 plc, commented: "We are delighted to announce the deal with Biodata for the exclusive rights toits people counting system when interfaced with public transport vehiclesystems. This technology, when coupled with 21st Century's two new products willgive greater control on revenue and reduced running costs for bus operators upand down the country. We are working with a major public transport company totrial these new products and look forward to updating the market further, in duecourse." Founded in Manchester over 30 years ago, Biodata originally developed technologyto link laboratory instruments with microcomputers. The product range soondeveloped to provide solutions for data acquisition and control problems andthey were one of the first measurement companies to achieve ISO 9001 (EN29001)certification. Biodata's people counting system is currently in use in over 20countries around the world. For more information go to www.videoturnstile.com Ends For enquiries please contact: Peter Ward Chairman or Wilson Jennings Finance Director 020 8710 4000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Dec 20247:00 amRNSContract Extension
9th Dec 202410:36 amRNSHolding(s) in Company
4th Dec 20241:34 pmRNSHolding(s) in Company
25th Nov 20247:00 amRNSPurchase Orders
15th Oct 20245:37 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSEstablishment of Long-Term Incentive Plan
17th Sep 20247:00 amRNSInterim Results
30th Jul 20247:00 amRNSTrading Update
29th Jul 20247:00 amRNSPurchase Order
16th Jul 20247:00 amRNSContract Awards
27th Jun 20241:17 pmRNSHolding(s) in Company
5th Jun 20244:03 pmRNSDirector/PDMR Shareholding
29th May 20245:25 pmRNSHolding(s) in Company
25th Apr 202411:40 amRNSDirector/PDMR Shareholding
25th Apr 20249:07 amRNSResult of AGM
22nd Apr 20247:00 amRNSService and support contract in Sweden
28th Mar 20247:00 amRNSPurchase Order
27th Mar 202410:33 amRNSDirector Share Purchases
26th Mar 20247:00 amRNSPurchase Orders
26th Mar 20247:00 amRNSFinal Results
21st Mar 20247:00 amRNSNotice of Results
11th Mar 20247:00 amRNSPurchase Orders
21st Feb 202410:52 amRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNS£5 million Framework Agreement
29th Jan 20244:54 pmRNSHolding(s) in Company
22nd Jan 20245:34 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 202411:46 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20237:01 amRNSMello Conference
28th Nov 20237:00 amRNSTrading Update
10th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 20237:00 amRNSChange of Nominated Adviser and Broker
11th Oct 20239:43 amRNSIssue of Equity
9th Oct 202310:27 amRNSIssue of Equity & PDMR Dealing
28th Sep 20237:00 amRNSHolding(s) in Company
26th Sep 20237:00 amRNSHalf-year Report
25th Sep 20238:25 amRNSHolding(s) in Company
22nd Sep 20237:00 amRNSPurchase Order
20th Sep 20237:00 amRNSAcquisition of MultiQ
11th Sep 202310:33 amRNSReplacement - Investor Presentation via IMC
11th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th Sep 20237:00 amRNSPurchase Orders
7th Aug 20237:00 amRNSHolding(s) in Company
4th Aug 20239:13 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSTrading Update
15th May 20237:00 amRNSPurchase Order
27th Apr 20231:58 pmRNSResult of AGM
18th Apr 20237:00 amRNSFramework agreement extension
3rd Apr 20237:00 amRNSEast Midlands Airport

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.